Time New York: Tue 20 Mar 21:31 pm  |  Save 15% on H&R Block Online


Cogentix Medical (CGNT) Looks Good: Stock Adds 13.3% in Session


Cogentix Medical, Inc. CGNT was a big mover last session, as the company saw its shares rise over 13% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the company’s recent uptrend – as the stock is now up 23.6% over past one month time frame.

The shares rose after the company announced that it has entered into a definitive merger agreement, under which Laborie Medical Technologies will acquire all of the outstanding shares of Cogentix Medical for a total consideration of approximately $239 million.

Cogentix Medical has seen one positive estimate revisions in the past two months. Its Zacks Consensus Estimate for the current quarter has also revised upward over the same time frame. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Cogentix Medical currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Cogentix Medical, Inc. Price and Consensus

A better ranked stock worth considering in the Medical – Instruments industry is Accuray Incorporated ARAY which sports a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is CGNT going up? Or down? Predict to see what others think: Up or Down

Zacks Top 10 Stocks for 2018

In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2018?

Last year's 2017 Zacks Top 10 Stocks portfolio produced double-digit winners, including FMC Corp. and VMware which racked up stellar gains of +67.9% and +61%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Don’t miss your chance to get in on these long-term buys.

Access Zacks Top 10 Stocks for 2018 today >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Zacks Investment Research
<-- You can share this post with your network,
or give us your opinion and leave a comment.
Be sure to check our RSS feeds for updates.